Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
BPC-157 is a synthetic peptide supplied as a lyophilized research compound for scientific investigation involving cellular signaling pathways, tissue-model analysis, and peptide interaction studies within controlled laboratory environments
The primary structural difference, tirzepatide dual GIP/GLP-1 activity versus semaglutide single GLP-1 activity, does not significantly affect storage stability
Recovery timelines are well-established, with most Grade 1 strains resolving in two to three weeks and Grade 2 strains requiring three to six weeks
As it is proangiogenic, it could enhance growth of cancer
Nevertheless, extending the half-life of BPC157 and further improving its pharmacokinetic characteristics are important directions for the future development of this drug
US$ 24.91
US$ 25.85
US$ 28.04
